Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
Details for Australian Patent Application No. 2010226726 (hide)
International Classifications
Event Publications
20 October 2011 PCT application entered the National Phase
PCT publication WO2010/107825 Priority application(s): WO2010/107825
17 May 2012 Assignment before Grant
Pangu Biopharma Limited The application has been assigned to Pangu Biopharma Limited; TYR Pharma, Inc.
11 October 2012 Corrigenda
Assignments Before Grant, Section 113 - 2010 Under the name TYR Pharma, Inc., Application No. 2010226726, Under INID (71), corrected the applicant name to aTYR Pharma, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010226757-Relative and absolute error models for subterranean wells
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser